Be a Smart Investor
Sunday, June 2, 2019
Not For The Faint-hearted Though...
The clinical trials can make or break drug companies as their stock price reaction can either be overwhelmingly positive or brutal depending upon the trial results.
from RTT - Biotech http://bit.ly/2HPCu66
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment